Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Sexually Transmitted Diseases

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 89 articles:
HTML format



Single Articles


    September 2025
  1. MATTHIAS KA, Connolly KL, Jerse AE, Kumova OK, et al
    Evaluation of Immunization Route in Induction of Vaccine-Mediated Anti-Gonococcal Immune Responses in a Murine Model of Ascending Infection.
    J Infect Dis. 2025 Sep 16:jiaf445. doi: 10.1093.
    PubMed     Abstract available



  2. Correction to: Impact and Cost-effectiveness of Regular Self-digital Anorectal Examination on Syphilis Among Gay, Bisexual, and Other Men Who Have Sex With Men: A Mathematical Modeling Study.
    J Infect Dis. 2025 Sep 10:jiaf465. doi: 10.1093.
    PubMed    


    August 2025
  3. CHURIWAL M, Kintu TM, Byamukama O, Bassett IV, et al
    HIV and syphilis coinfection in pregnancy and adverse birth outcomes in Uganda.
    J Infect Dis. 2025 Aug 30:jiaf453. doi: 10.1093.
    PubMed     Abstract available


  4. BENARD EA, Carceller AM, Mayrand MH, Lacroix J, et al
    Human Papillomavirus Persistence, Recurrence, and Incidence in Early Childhood.
    J Infect Dis. 2025;232:e213-e222.
    PubMed     Abstract available


  5. WOLFE C, Ionescu IG, Mayrand MH, Coutlee F, et al
    Prevalence of Human Papillomavirus Genotypes in Unvaccinated 16- to 20-Year-Old Men in Quebec, Canada.
    J Infect Dis. 2025;232:e203-e212.
    PubMed     Abstract available


    July 2025
  6. LAUMEN JGE, Hieu VN, Nhung PH, Vandelannoote K, et al
    High Prevalence of Ceftriaxone-Resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023-2024.
    J Infect Dis. 2025;232:e73-e77.
    PubMed     Abstract available


  7. SHIMUTA K, Ohama Y, Ito S, Hoshina S, et al
    Emergence of Ceftriaxone-Resistant Neisseria gonorrhoeae Through Horizontal Gene Transfer Among Neisseria Species.
    J Infect Dis. 2025;232:152-161.
    PubMed     Abstract available


  8. LIU A, Giacani L, Tuero I, Klausner JD, et al
    Syphilis Pathogenesis: Host Immune Response versus Pathogen Immune Evasion.
    J Infect Dis. 2025 Jul 23:jiaf388. doi: 10.1093.
    PubMed     Abstract available


  9. ALLEN VG
    Novel and Effective Approach to Reducing Syphilis Among Gay and Bisexual Men Who Have Sex With Men Using Anorectal Digital Self-examination.
    J Infect Dis. 2025 Jul 15:jiaf311. doi: 10.1093.
    PubMed    


  10. LAI H, Fairley CK, Li R, Chen MY, et al
    Impact and Cost-effectiveness of Regular Self-digital Anorectal Examination on Syphilis Among Gay, Bisexual, and Other Men Who Have Sex With Men: A Mathematical Modeling Study.
    J Infect Dis. 2025 Jul 15:jiaf310. doi: 10.1093.
    PubMed     Abstract available


  11. TZENG YL, Esposito DLA, Nederveld AG, Hardison RL, et al
    The Neisseria meningitidis Urethritis Clade (NmUC) Acts as a "Chimeric Pathogen" During Infection of Primary, Human Male, Urethral Epithelial Cells.
    J Infect Dis. 2025;231:1478-1488.
    PubMed     Abstract available


  12. HETLAND FALKENTHAL TE, Nygard S, Nygard M
    Beyond Women's Health: Long-Term HPV-related Cancer Trends in Norway.
    J Infect Dis. 2025 Jul 9:jiaf351. doi: 10.1093.
    PubMed     Abstract available


  13. WANG C, Wei J, Yang D
    Addressing Gaps in the Study of Neutralizing Antibody Responses to Chlamydia trachomatis.
    J Infect Dis. 2025 Jul 7:jiaf231. doi: 10.1093.
    PubMed    


    April 2025
  14. RONN MM, Chesson HW, Grad YH, Reitsma M, et al
    The influence of epidemiological context on the success of partner notification programs: analysis of gonorrhea transmission dynamics.
    J Infect Dis. 2025 Apr 18:jiaf206. doi: 10.1093.
    PubMed     Abstract available


  15. YAN RL, Xu Y, Tong J, Chen P, et al
    Serological Responses and Pregnancy Outcomes in Women with Serofast Syphilis: Efficacy of Re-treatment in a Prospective Nested Case-Control Study.
    J Infect Dis. 2025 Apr 15:jiaf193. doi: 10.1093.
    PubMed     Abstract available


  16. GRAY P, Wang J, Nordqvist Kleppe S, Elfstrom KM, et al
    Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus Prevalence.
    J Infect Dis. 2025;231:e638-e649.
    PubMed     Abstract available


  17. WILLIAMS E, Hocking JS, Fairley CK, Chen MY, et al
    Rationale and Ethical Assessment of an Oropharyngeal Gonorrhea Controlled Human Infection Model.
    J Infect Dis. 2025;231:841-848.
    PubMed     Abstract available


    March 2025
  18. RYAN JD, Ardizzone CM, Jordan SJ, Williams JA, et al
    Non-invasive monitoring of humoral immune responses in men with acute Chlamydia trachomatis urethral infection using first-catch urine.
    J Infect Dis. 2025 Mar 17:jiaf139. doi: 10.1093.
    PubMed     Abstract available


    February 2025
  19. WIJEKOON D, Chen MY, Hughes Y, Fairley CK, et al
    Routine treatment versus selective treatment for individuals reporting contact with sexual partners with chlamydia: A Before-and-After Study.
    J Infect Dis. 2025 Feb 27:jiaf107. doi: 10.1093.
    PubMed     Abstract available


  20. HOLSTER T, Joki-Korpela P, Yu H, Brunham RC, et al
    Serum IgG1 and IgG3 antibody responses to Chlamydia trachomatis Pgp3 and Hsp60 in tubal factor infertility.
    J Infect Dis. 2025 Feb 21:jiaf092. doi: 10.1093.
    PubMed     Abstract available


    January 2025
  21. ASTORGA ALSINA AM, Herweijer E, Lei J
    Population-level Impact of HPV Vaccination on the Incidence of Genital Warts in Sweden.
    J Infect Dis. 2025 Jan 29:jiaf052. doi: 10.1093.
    PubMed     Abstract available


  22. LIU C, Guo Y, Wang L, Guo R, et al
    Association Between Herpes Simplex Virus Type II and High-Risk Human Papillomavirus Infections: A Population Study of the National Health and Nutrition Examination Survey, 2009-2016.
    J Infect Dis. 2025 Jan 15:jiaf033. doi: 10.1093.
    PubMed     Abstract available


    December 2024
  23. SUOMINEN H, Syrjanen K, Waterboer T, Grenman S, et al
    Serum Immunoglobulin G Antibodies to Human Papillomavirus Type 6 L1, E2, E4, E6, and E7 Proteins Among Children Prospectively Followed up for 3 Years.
    J Infect Dis. 2024;230:e1207-e1213.
    PubMed     Abstract available


  24. CASTO AM, Song H, Xie H, Selke S, et al
    Viral Genomic Variation and the Severity of Genital Herpes Simplex Virus-2 Infection as Quantified by Shedding Rate: A Viral Genome-Wide Association Study.
    J Infect Dis. 2024;230:1357-1366.
    PubMed     Abstract available


    November 2024
  25. STRICKLER HD, Usyk M, Eltoum IE, Bachman N, et al
    Case-Control Study of Cervicovaginal Beta-/Gamma-HPV Infection in Women with HIV and Its Relation with Incident Cervical Precancer.
    J Infect Dis. 2024 Nov 27:jiae588. doi: 10.1093.
    PubMed     Abstract available


  26. NYGARD S, Falkenthal T, Sture T, Lynge E, et al
    Impact of multi-cohort HPV vaccination on cervical cancer in women below 30 years of age: Lessons learned from the Scandinavian countries.
    J Infect Dis. 2024 Nov 21:jiae584. doi: 10.1093.
    PubMed     Abstract available


    October 2024
  27. YU H, Geisler WM, Dai C, Gupta K, et al
    Neutralizing Antibody Responses to Chlamydia trachomatis in Women and Associations with Chlamydia Outcomes.
    J Infect Dis. 2024 Oct 22:jiae519. doi: 10.1093.
    PubMed     Abstract available


  28. STOVER EL, Little MB, Connolly KL, Li L, et al
    Development and Validation of Multiplex Assays for Mouse and Human IgG and IgA to Neisseria gonorrhoeae Antigens.
    J Infect Dis. 2024;230:852-856.
    PubMed     Abstract available


    September 2024
  29. KUSTERS JMA, Schim van der Loeff MF, Heijne JCM, King AJ, et al
    Changes in Genital HPV Prevalence during 12 Years Girls-Only Bivalent HPV Vaccination: Results from a Biennial Repeated Cross-Sectional Study.
    J Infect Dis. 2024 Sep 13:jiae455. doi: 10.1093.
    PubMed     Abstract available


  30. LI Y, Warren JA, Poston TB, Clutton G, et al
    Chlamydia trachomatis induces low-frequency, sustained CD4 T cell responses in most women, predominantly targeting chlamydial protease-like activity factor, CPAF.
    J Infect Dis. 2024 Sep 9:jiae443. doi: 10.1093.
    PubMed     Abstract available


    August 2024
  31. BALGOVIND P, Aung E, Shilling H, Murray GL, et al
    Human papillomavirus prevalence among Australian men aged 18-35 years in 2015-2018 according to vaccination status and sexual preference.
    J Infect Dis. 2024 Aug 30:jiae412. doi: 10.1093.
    PubMed     Abstract available


  32. SALAZAR JC, Radolf JD
    T-Cell Responses to Treponema pallidum Proteins in Blood and Skin to Advance Syphilis Vaccine Design: Learning From Nature.
    J Infect Dis. 2024;230:275-277.
    PubMed    


  33. DESISTO CL, Winer RL, Querec TD, Dada D, et al
    Vaccine effectiveness against anal HPV among men who have sex with men aged 18-45 years attending sexual health clinics in three United States cities, 2018-2023.
    J Infect Dis. 2024 Aug 8:jiae394. doi: 10.1093.
    PubMed     Abstract available


    July 2024
  34. ABARA WE, Kirkcaldy RD, Bernstein KT, Galloway E, et al
    Effectiveness of MenB-4C vaccine against gonorrhea: a systematic review and meta-analysis.
    J Infect Dis. 2024 Jul 31:jiae383. doi: 10.1093.
    PubMed     Abstract available


  35. TANTALO LC, Luetkemeyer A, Lieberman NAP, Nunley BE, et al
    Long-term in vitro exposure of Treponema pallidum to sub-bactericidal doxycycline did not induce resistance: Implications for doxy-PEP and syphilis.
    J Infect Dis. 2024 Jul 27:jiae381. doi: 10.1093.
    PubMed     Abstract available



  36. Correction to: High Risk of New HPV Infection Acquisition Among Unvaccinated Young Men.
    J Infect Dis. 2024;230:e220.
    PubMed    


  37. WATERS MB, Hybiske K, Ikeda R, Kaltenboeck B, et al
    Chlamydia trachomatis Seroassays Used in Epidemiologic Research: A Narrative Review and Practical Considerations.
    J Infect Dis. 2024;230:250-262.
    PubMed     Abstract available


  38. COMBES JD, Didelot JM, Radenne S, Zaegel-Faucher O, et al
    Cumulative Detection of Anal High-Grade Squamous Intraepithelial Lesions Over 2-Year Follow-up in Men Who Have Sex With Men Living With Human Immunodeficiency Virus in France.
    J Infect Dis. 2024;230:55-60.
    PubMed     Abstract available


    June 2024
  39. REID TB, Godornes C, Campbell VL, Laing KJ, et al
    Treponema pallidum Periplasmic and Membrane Proteins Are Recognized by Circulating and Skin CD4+ T Cells.
    J Infect Dis. 2024 Jun 27:jiae245. doi: 10.1093.
    PubMed     Abstract available


  40. YANG L, Zhang X, Chen W, Sena AC, et al
    Clinical presentation of early syphilis and genomic sequences of Treponema pallidum strains in patient specimens and isolates obtained by rabbit inoculation.
    J Infect Dis. 2024 Jun 17:jiae322. doi: 10.1093.
    PubMed     Abstract available


  41. CHOW EPF, Stevens K, De Petra V, Chen MY, et al
    Prevalence of cefixime-resistant Neisseria gonorrhoeae in Melbourne, Australia, 2021-2022.
    J Infect Dis. 2024 Jun 15:jiae313. doi: 10.1093.
    PubMed     Abstract available


    May 2024
  42. RUIZ GARCIA Y, Marrazzo J, Martinon-Torres F, Workowski K, et al
    Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context.
    J Infect Dis. 2024 May 31:jiae289. doi: 10.1093.
    PubMed     Abstract available


  43. LI M, Yang J, Zhou L, Zhang J, et al
    Efficacy of a novel affitoxin targeting MOMP against Chlamydia trachomatis in vitro and in vivo.
    J Infect Dis. 2024 May 9:jiae257. doi: 10.1093.
    PubMed     Abstract available


    April 2024
  44. ORUMAA M, Lahlum EJ, Gulla M, Tota J, et al
    Quadrivalent HPV vaccine effectiveness against cervical intraepithelial lesion grade 2 or worse in Norway: A registry-based study of 0,9 million Norwegian women.
    J Infect Dis. 2024 Apr 25:jiae209. doi: 10.1093.
    PubMed     Abstract available


  45. WATERS MB, Hybiske K, Ikeda R, Kaltenboeck B, et al
    Chlamydia trachomatis seroassays used in epidemiologic research: a narrative review and practical considerations.
    J Infect Dis. 2024 Apr 19:jiae199. doi: 10.1093.
    PubMed     Abstract available


  46. NIKITIN D, Whittles LK, Imai-Eaton JW, White PJ, et al
    Cost-effectiveness of 4CMenB vaccination against gonorrhea: importance of dosing schedule, vaccine sentiment, targeting strategy, and duration of protection.
    J Infect Dis. 2024 Apr 17:jiae123. doi: 10.1093.
    PubMed     Abstract available


  47. MURENZI G, Kim HY, Mivumbi JP, Gasana J, et al
    Incidence, Clearance and Persistence of Penile High-Risk Human Papillomavirus among Rwandan Men who have Sex with Men.
    J Infect Dis. 2024 Apr 16:jiae190. doi: 10.1093.
    PubMed     Abstract available


    March 2024
  48. CHEN W, Zhou C, Su X, Yin X, et al
    Revealing the Genetic Diversity of Chinese Chlamydia trachomatis Strains Directly from Clinical Samples through Selective Whole-Genome Amplification.
    J Infect Dis. 2024 Mar 28:jiae163. doi: 10.1093.
    PubMed     Abstract available



  49. Correction to: High Risk of New HPV Infection Acquisition Among Unvaccinated Young Men.
    J Infect Dis. 2024 Mar 22:jiae121. doi: 10.1093.
    PubMed    


  50. MUNK C, Reinholdt K, Kjaer AK, Hemmingsen CH, et al
    Prevalence of Human Papillomavirus (HPV) and HPV Type Distribution in Penile Samples in Young Men in Denmark: Results 10 Years After Implementation of a Girls-Only HPV Vaccination Program.
    J Infect Dis. 2024 Mar 12:jiae068. doi: 10.1093.
    PubMed     Abstract available


    February 2024
  51. DZIADULA J, Sabbaj S, Gupta K, Cutter G, et al
    Interferon-Gamma Responses to Chlamydia trachomatis Vaccine Candidate Proteins in Chlamydia-Infected Women with Different Chlamydia Outcomes.
    J Infect Dis. 2024 Feb 23:jiae092. doi: 10.1093.
    PubMed     Abstract available


    January 2024
  52. BROWN EE, Patel EU, Poteat TC, Mayer K, et al
    Prevalence of sexually transmitted infections among transgender women living with and without HIV in the eastern and southern United States.
    J Infect Dis. 2024 Jan 17:jiad605. doi: 10.1093.
    PubMed     Abstract available


    December 2023
  53. LEI W, Wen Y, Yang Y, Liu S, et al
    Chlamydia trachomatis T3SS effector CT622 induces proinflammatory cytokines through TLR2/TLR4-mediated MAPKs/NF-kappaB pathways in THP-1 cells.
    J Infect Dis. 2023 Dec 26:jiad597. doi: 10.1093.
    PubMed     Abstract available


  54. TEDIJANTO C, Aragie S, Gwyn S, Wittberg DM, et al
    Seroreversion to Chlamydia trachomatis Pgp3 antigen among children in a hyperendemic region of Amhara, Ethiopia.
    J Infect Dis. 2023 Dec 22:jiad602. doi: 10.1093.
    PubMed     Abstract available


  55. LUCERO-OBUSAN C, Oda G, Schirmer P, Edson C, et al
    Epidemiology of the 2022 Mpox Outbreak in the US Veterans Health Administration.
    J Infect Dis. 2023 Dec 22:jiad600. doi: 10.1093.
    PubMed     Abstract available


  56. DIONNE JA, Giacani L, Tamhane A, Workowski K, et al
    Prevalence and Predictors of Oral Treponema pallidum Detection by qPCR in Early Syphilis.
    J Infect Dis. 2023 Dec 21:jiad582. doi: 10.1093.
    PubMed     Abstract available


    November 2023
  57. GIULIANO AR, Palefsky JM, Goldstone SE, Dubin B, et al
    High Risk of New HPV Infection Acquisition Among Unvaccinated Young Men.
    J Infect Dis. 2023 Nov 28:jiad485. doi: 10.1093.
    PubMed     Abstract available


  58. MORRILL SR, Saha S, Varki AP, Lewis WG, et al
    Gardnerella Vaginolysin Potentiates Glycan Molecular Mimicry by Neisseria gonorrhoeae.
    J Infect Dis. 2023;228:1610-1620.
    PubMed     Abstract available


  59. SKARGA E, Surcel HM, Kaaks R, Waterboer T, et al
    Sexually Transmitted Infections and Risk of Epithelial Ovarian Cancer: Results From the Finnish Maternity Cohort.
    J Infect Dis. 2023;228:1621-1629.
    PubMed     Abstract available


  60. PHILLIPS LT, Witney AA, Furegato M, Laing KG, et al
    Time Required for Nanopore Whole-Genome Sequencing of Neisseria gonorrhoeae for Identification of Phylogenetic Relationships.
    J Infect Dis. 2023;228:1179-1188.
    PubMed     Abstract available


    October 2023
  61. KUSTERS JMA, Brouwer JGM, van Benthem BHB, Heijne JCM, et al
    Global Type-Specific Genital Human Papillomavirus Prevalence in Men, by Sexual Orientation: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2023;228:1023-1032.
    PubMed     Abstract available


  62. HALL CDX, Ryan D, Hayford C, Morgan E, et al
    Syphilis Prevalence, Incidence, and Demographic Differences in a Longitudinal Study of Young Sexual and Gender Minority Adults Assigned Male at Birth.
    J Infect Dis. 2023 Oct 10:jiad256. doi: 10.1093.
    PubMed     Abstract available


  63. FENG E, Monteiro JK, Portillo AL, Balint E, et al
    Natural Killer Cell-Derived Interferon-gamma Regulates Macrophage-Mediated Immunopathology During Viral Infection.
    J Infect Dis. 2023;228:834-839.
    PubMed     Abstract available


    September 2023
  64. LIEBERMAN NAP, Avendano CC, Bakhash SAKM, Nunley E, et al
    Genomic Epidemiology of Treponema pallidum and Circulation of Strains With Diminished tprK Antigen Variation Capability in Seattle, 2021-2022.
    J Infect Dis. 2023 Sep 28:jiad368. doi: 10.1093.
    PubMed     Abstract available


  65. SALYARDS M, Nijhawan AE, Kuo J, Knights SM, et al
    Prevalence, Incidence, and Predictors of Kaposi Sarcoma-associated Herpesvirus Infection Among Young Men Who Have Sex with Men in the Southern United States.
    J Infect Dis. 2023 Sep 15:jiad384. doi: 10.1093.
    PubMed     Abstract available


    August 2023
  66. AL-SONEIDAR WA, Harper S, Coutlee F, Gheit T, et al
    Prevalence of Alpha, Beta, and Gamma Human Papillomaviruses (HPV) in head and neck cancer patients and non-cancer controls and relation to behavioral factors.
    J Infect Dis. 2023 Aug 16:jiad335. doi: 10.1093.
    PubMed     Abstract available


  67. CLARK JL, Oldenburg CE, Passaro RC, Segura ER, et al
    Changes in Inflammatory Cytokine Levels in Rectal Mucosa Associated with Neisseria Gonorrheae and/or Chlamydia trachomatis Infection and Treatment Among Men Who Have Sex with Men in Lima, Peru.
    J Infect Dis. 2023 Aug 16:jiad349. doi: 10.1093.
    PubMed     Abstract available


  68. MALAGON T, Trottier H, El-Zein M, Villa LL, et al
    Human Papillomavirus Intermittence and Risk Factors Associated With First Detections and Redetections in the Ludwig-McGill Cohort Study of Adult Women.
    J Infect Dis. 2023;228:402-411.
    PubMed     Abstract available


  69. SUOMINEN NT, Luukkaala TH, Laprise C, Haataja MA, et al
    Human papillomavirus concordance between parents and their newborn offspring: Results from the Finnish Family HPV study.
    J Infect Dis. 2023 Aug 10:jiad330. doi: 10.1093.
    PubMed     Abstract available


    July 2023
  70. LI X, Ling Y, Hu L, Zhang L, et al
    Detection of HPV DNA, E6/E7 mRNA, and p16INK4a in lung cancer: A systematic review and meta-analysis.
    J Infect Dis. 2023 Jul 28:jiad295. doi: 10.1093.
    PubMed     Abstract available


  71. TANG Y, Liu X, Chen W, Luo X, et al
    Antimicrobial Resistance Profiling and Genome Analysis of the penA-60.001 Neisseria gonorrhoeae Clinical Isolates in China in 2021.
    J Infect Dis. 2023 Jul 18:jiad258. doi: 10.1093.
    PubMed     Abstract available


  72. BRAMBLE JAT, Pepperell CS
    Making sense of the past: Columbus and the European syphilis epidemic.
    J Infect Dis. 2023 Jul 13:jiad249. doi: 10.1093.
    PubMed    


  73. OUMAROU HAMA H, Boualam MA, Levasseur A, Ardagna Y, et al
    Old World medieval Treponema pallidum complex treponematosis: a case report.
    J Infect Dis. 2023 Jul 13:jiad248. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  74. FERREIRA MT, Mendoza Lopez RV, Goncalves MG, Ferreira S, et al
    HPV-16 lineage A variants are associated with persistent genital infections in men: The HIM Study.
    J Infect Dis. 2023 Jun 4:jiad204. doi: 10.1093.
    PubMed     Abstract available


    May 2023
  75. WEI F, Alberts CJ, Albuquerque A, Clifford GM, et al
    Impact of human papillomavirus vaccine against anal human papillomavirus infection, anal intraepithelial neoplasia, and recurrence of anal intraepithelial neoplasia: a systematic review and meta-analysis.
    J Infect Dis. 2023 May 31:jiad183. doi: 10.1093.
    PubMed     Abstract available


  76. MORAIS S, Wissing MD, Khosrow-Khavar F, Burchell AN, et al
    Serologic Response to Human Papillomavirus Genotypes Among Unvaccinated Women: Findings From the HITCH Cohort Study.
    J Infect Dis. 2023;227:1173-1184.
    PubMed     Abstract available


  77. JORDAN SJ, Wilson L, Ren J, Gupta K, et al
    Natural clearance of Chlamydia trachomatis infection is associated with distinct differences in cervicovaginal metabolites.
    J Infect Dis. 2023 May 11:jiad155. doi: 10.1093.
    PubMed     Abstract available


  78. LIN HY, Fu Q, Tseng TS, Zhu X, et al
    Impact of Dietary Quality on Genital Oncogenic HPV Infection in Women.
    J Infect Dis. 2023 May 10:jiad146. doi: 10.1093.
    PubMed     Abstract available


  79. BROWN SE, Tuddenham S, Shardell MD, Klebanoff MA, et al
    Bacterial vaginosis and spontaneous clearance of Chlamydia trachomatis in the Longitudinal Study of Vaginal Flora.
    J Infect Dis. 2023 May 9:jiad142. doi: 10.1093.
    PubMed     Abstract available


    April 2023
  80. WHITTLES LK, Galiwango RM, Mpagazi J, Tobian AAR, et al
    Age patterns of HSV-2 incidence and prevalence in two Ugandan communities: a catalytic incidence model applied to population-based seroprevalence data.
    J Infect Dis. 2023 Apr 20:jiad113. doi: 10.1093.
    PubMed     Abstract available


  81. CLIFFORD GM, Wei F
    Prevention of Human Papillomavirus-Related Anal Cancer in Women Living With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:929-931.
    PubMed    


  82. LIU Y, Weiss K, Zamudio AR, Hayes MP, et al
    Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:932-938.
    PubMed     Abstract available


  83. BRISTOW CC, Mortimer TD, Morris S, Grad YH, et al
    Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae.
    J Infect Dis. 2023;227:917-925.
    PubMed     Abstract available


    March 2023
  84. VAN EER K, Middeldorp M, Dzebisasjvili T, Lamkaraf N, et al
    Effects of two and three vaccinations with the bivalent HPV vaccine on the prevalence and load of HPV in clearing and persistent infections in young women.
    J Infect Dis. 2023 Mar 29:jiad080. doi: 10.1093.
    PubMed     Abstract available


  85. LUO Y, Wang C, Du Z, Wang C, et al
    NO-producing Polymorphonuclear Neutrophils Confer Protection against Chlamydia psittaci in Mouse Lung Infection.
    J Infect Dis. 2023 Mar 24:jiad072. doi: 10.1093.
    PubMed     Abstract available


  86. WHITE JL, Grabowski MK, Rositch AF, Gravitt PE, et al
    Trends in adolescent human papillomavirus vaccination and parental hesitancy in the United States.
    J Infect Dis. 2023 Mar 3:jiad055. doi: 10.1093.
    PubMed     Abstract available


    February 2023
  87. LI Y, You S, Lee K, Yaesoubi R, et al
    The estimated lifetime quality-adjusted life-years lost due to chlamydia, gonorrhea, and trichomoniasis in the United States in 2018.
    J Infect Dis. 2023 Feb 18:jiad047. doi: 10.1093.
    PubMed     Abstract available


    January 2023
  88. CHAMBERS C, Deeks SL, Sutradhar R, Cox J, et al
    Vaccine effectiveness against 12-month incident and persistent anal human papillomavirus infection among gay, bisexual, and other men who have sex with men.
    J Infect Dis. 2023 Jan 19:jiad005. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  89. LI Z, Winer RL, Ba S, Sy MP, et al
    Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance among Women in Senegal, West Africa.
    J Infect Dis. 2022 Oct 31. pii: 6782258. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.